Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02672332 · ClinicalTrials.gov registry record · Phase 3
P3 Study in Acne Comparing Once Daily SB204 and Vehicle
A Phase 3 study, sponsored by Novan.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,307
- Enrollment target
NCT02672332 is a Phase 3 study that has completed, run by Novan. The registered enrollment target is 1,307 participants.
The verdict
NCT02672332, a Phase 3 study, has completed, sponsored by Novan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,307 participants
- Enrollment target
Study Summary
This is a 12 week, multi-center, double-blinded, randomized, vehicle-controlled, parallel group, study to be conducted in approximately 1300 subjects with acne vulgaris in the US.
Interventions
- DRUG Vehicle Gel
- DRUG SB204 4%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,307 participants |
| Start Date | 2016-02-22 |
| Est. Completion | 2016-12-21 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02672332
The ClinicalTrials.gov registry entry for NCT02672332 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,307 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novan, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle Gel is the first listed.
NCT02672332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02672332 about?
NCT02672332 is a clinical study titled "P3 Study in Acne Comparing Once Daily SB204 and Vehicle". This is a 12 week, multi-center, double-blinded, randomized, vehicle-controlled, parallel group, study to be conducted in approximately 1300 subjects with acne vulgaris in the US.
What is the current status of trial NCT02672332?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,307 participants. The study started on 2016-02-22. Estimated completion is 2016-12-21.
What interventions are being tested in trial NCT02672332?
The interventions under investigation include: Vehicle Gel (DRUG), SB204 4% (DRUG).
Who is sponsoring clinical trial NCT02672332?
This trial is sponsored by Novan, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.